Phosphomannopentaose Sulfate (PI-88): Heparan Sulfate Mimetic with Clinical Potential in Multiple Vascular Pathologies

Medicine and Dentistry

• Vascular Disease 100%
• Heparan Sulfate 100%
• Oligosaccharide 50%
• Growth Factor 33%
• Antiangiogenic 33%
• Clinical Trial 16%
• Injury 16%
• Vasculotropin 16%
• Antithrombotic 16%
• Receptor 16%
• Antiangiogenic Activity 16%
• Fibroblast Growth Factor 2 16%
• Cell Proliferation 16%
• Vascular Smooth Muscle Cell 16%
• Heparanase 16%
• Cell Surface 16%
• Antimetastatic Agent 16%
• Kinase Signaling 16%
• Heparin Cofactor II 16%
• Artery Intima Proliferation 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Heparan Sulfate 100%
• Vascular Disease 100%
• Antiangiogenic 50%
• Oligosaccharide 50%
• Growth Factor 33%
• Clinical Trial 16%
• Injury 16%
• Vasculotropin 16%
• Heparanase 16%
• Receptor 16%
• Anticoagulant Agent 16%
• Fibroblast Growth Factor 2 16%
• Phosphotransferase 16%
• Artery Intima Proliferation 16%
• Heparin Cofactor II 16%
• Antimetastatic Agent 16%

Immunology and Microbiology

• Growth Factor 100%
• Vasculotropin 50%
• Cell Proliferation 50%
• Fibroblast Growth Factor 2 50%
• Antiangiogenic Activity 50%
• Cell Surface 50%
• Vascular Smooth Muscle Cell 50%